|Last Price$20.64||Day Change (%)1.23%|
|Open Price$20.16||Day Change ($)0.25|
|Day Range20.01–21.02||52-Week Range7.56–23.03|
As of Fri 05/24/2013 02:17 AM EDT | USD
Isis Pharmaceuticals Earns $3.5 Million from Biogen Idec
Good day, ladies and gentlemen, and welcome to Isis Pharmaceuticals' Second Quarter Financial Results Conference Call. Leading the call today from Isis is Dr. Stanley Crook, Isis's Chairman and Chief Executive Officer. Dr. Crook, please begin.
DPR Construction’s Phoenix Office First Net-Zero Energy Commercial Building in Arizona
Menlo Completes Registered Agent Certification for Dutch Facilities
USA Technologies Reports Financial Results for Third Quarter of Fiscal 2013
Week ending Nov. 10: Investors remain optimistic about direction of economy.
Cloud-based document management services aren't new, but the leading provider of on-premises software for advisors is expanding its offering with a new online service.
Advisors can bank on these software and hardware picks.